Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Vivani Medical, Inc.NASDAQ: VANI
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings remains negative
Q1 FY2026 retained earnings was -$155.31M, compared with -$128.23M a year earlier.
Context
- Retained earnings amounted to 366.7% of total assets at the end of Q1 FY2026, up 5.0 pp from a year earlier.
- Retained earnings grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether retained earnings keeps falling in the next quarterly balance sheet after a -21.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (148.53M) USD
- Year-over-year change
- -21.8%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (148.53M) | -21.8% |
| FY2024 | 2024-12-31 | (121.92M) | -23.9% |
| FY2023 | 2023-12-31 | (98.44M) | -35.2% |
| FY2022 | 2022-12-31 | (72.79M) | -23.6% |
| FY2021 | 2021-12-31 | (58.9M) | — |
Retained Earnings vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -21.1% is the lowest of 8, against a peer median of -11.4%.
- Retained earnings amounts to 366.7% of total assets for VANI, versus a peer median of 176.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $672K USD | +111.2% | — | 0.3% | |
| Mar 2026 | -$85.12M USD | +53.8% | — | 31.7% | |
| Mar 2026 | -$107.76M USD | -15.2% | — | 138.0% | |
| Mar 2026 | -$155.31M USD | -21.1% | — | 366.7% | |
| Mar 2026 | -CA$224.47M CAD | -19.7% | — | 712.9% | |
IMAImageneBio Inc | Mar 2026 | -$240.67M USD | +29.3% | — | 176.1% |
| Mar 2026 | -$338.64M USD | -11.4% | — | 561.2% | |
| Mar 2026 | -$419.01M USD | -12.1% | — | 812.9% | |
| Peer median (excluding VANI) | — | -11.4% | — | 176.1% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.